CVS Pharmacy Inc. is paying $5 million to settle allegations that nine pharmacies in California failed to keep records for controlled substances in violation of federal law.
The administrative settlement with the Drug Enforcement Administration and the U.S. Attorney for the Eastern District of California resolves violations the DEA uncovered during a 2012 investigation after CVS self-reported thefts and loss of hydrocodone at five Sacramento-area stores, according to the U.S. Attorney’s Office.
“The nation is in the midst of an opioid crisis and all entities that distribute controlled substances must hold the frontline,” DEA Special Agent in Charge John J. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.